Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchSelect treatment..Select..
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

 

Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis

Sorensen et al., The Lancet, doi:10.1016/S0140-6736(21)02867-1, Apr 2022
https://c19early.org/sorensen.html
Systematic analysis of COVID-19 infection-fatality ratio (IFR) variation by age, time, and geography, using data from 2,073 seroprevalence surveys and mortality data from multiple countries. The study found substantial heterogeneity in IFR, with age being the strongest determinant: IFR followed a J-shaped curve with lowest risk at age 7 years (0.0023%) and increasing exponentially with age to 20.33% at age 90. Population age structure accounted for 74% of IFR variation between countries.
Sorensen et al., 30 Apr 2022, peer-reviewed, 79 authors, study period 15 April, 2020 - 1 January, 2021. Contact: rsoren@uw.edu.
Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis
PhD, R M Barber BS Reed J D Sorensen, Melinda Gates Foundation, J Stanton, T Gillespie, Ryan M Barber, PhD David M Pigott, Austin Carter, Cory N Spencer, PhD, R C Reiner Samuel M Ostroff Jr, Robert C Reiner Jr, Cristiana Abbafati, Christopher Adolph, PhD Adrien Allorant, PhD Joanne O Amlag, MPH Aleksandr Y Aravkin, Steven D Bachmeier, Bree L Bang-Jensen, Catherine Bisignano, Sabina S Bloom, Rachel Castellano, MS Emma Castro, BS, H Comfort MPH James K Collins, Haley Comfort, PhD, W J Xiaochen Dai, William James Dangel, Carolyn Dapper, Amanda Deen, Lucas Earl, Megan Erickson, Samuel B Ewald, PhD Alize J Ferrari, PhD, J J Frostad MPH, N Fullman MPH Abraham D Flaxman, Joseph Jon Frostad, Nancy Fullman, Amiran Gamkrelidze, PhD, G Guo MPH, J He MSc John R Giles, Gaorui Guo, Jiawei He, Monika Helak, MPH, B M Erin N Hulland, Bethany M Huntley, Maia Kereselidze, BSc, K E LeGrand MPH, E Linebarger BA Alice Lazzar-Atwood, Kate E Legrand, Akiaja Lindstrom, Emily Linebarger, Prof Rafael Lozano, Beatrice Magistro, Deborah Carvalho Malta, MD Johan Månsson, Mantilla Herrera, Fatima Marinho, Alemnesh H Mirkuzie, MS Ali H Mokdad, Lorenzo Monasta, Prof Mohsen Naghavi, Hasan Nassereldine, Shuhei Nomura, Christopher M Odell, Tesfaye Latera, Maja Olana, Spencer A Pasovic, Louise Pease, Grace Penberthy, Antonio Reinke, P Luiz, Damian Francesco Ribeiro, Aleksei Santomauro, Natia Sholokhov, Emma Elizabeth Skhvitaridze, Ruri Spurlock, Roman Syailendrawati, Anh Truc Topor-Madry, Theo Vo, Rebecca Vos, Ally Walcott, Stefanie Walker, Charles Shey Watson, Nahom Alemseged Wiysonge, Peng Worku, Simon I Zheng, Emmanuela Hay, Gakidou, J L Christopher, Murray, A Carter Mph, C N, Spencer Ba, MS, B L Bang-Jensen Ma, S S Bloom BA Bisignano Mph, Dangel Med, MS B Ewald, Helak Ba, Huntley Ba, PhD, H Nassereldine MD, C M Odell Mpp, Pasovic Med, BS S A Pease, MS L Penberthy, G Reinke, PhD, A Sholokhov MSc, E E Spurlock MPH F Santomauro, A T Vo BSc Syailendrawati Ma, Prof T Vos, Walker Ma, MS S Watson, PhD P Zheng, Prof E Gakidou
The Lancet, doi:10.1016/s0140-6736(21)02867-1
Background The infection-fatality ratio (IFR) is a metric that quantifies the likelihood of an individual dying once infected with a pathogen. Understanding the determinants of IFR variation for COVID-19, the disease caused by the SARS-CoV-2 virus, has direct implications for mitigation efforts with respect to clinical practice, non-pharmaceutical interventions, and the prioritisation of risk groups for targeted vaccine delivery. The IFR is also a crucial parameter in COVID-19 dynamic transmission models, providing a way to convert a population's mortality rate into an estimate of infections. Methods We estimated age-specific and all-age IFR by matching seroprevalence surveys to total COVID-19 mortality rates in a population. The term total COVID-19 mortality refers to an estimate of the total number of deaths directly attributable to COVID-19. After applying exclusion criteria to 5131 seroprevalence surveys, the IFR analyses were informed by 2073 all-age surveys and 718 age-specific surveys (3012 age-specific observations). When seroprevalence was reported by age group, we split total COVID-19 mortality into corresponding age groups using a Bayesian hierarchical model to characterise the non-linear age pattern of reported deaths for a given location. To remove the impact of vaccines on the estimated IFR age pattern, we excluded age-specific observations of seroprevalence and deaths that occurred after vaccines were introduced in a location. We estimated age-specific IFR with a non-linear meta-regression and used the resulting age pattern to standardise all-age IFR observations to the global age distribution. All IFR observations were adjusted for baseline and waning antibody-test sensitivity. We then modelled age-standardised IFR as a function of time, geography, and an ensemble of 100 of the top-performing covariate sets. The covariates included seven clinical predictors (eg, age-standardised obesity prevalence) and two measures of health system performance. Final estimates for 190 countries and territories, as well as subnational locations in 11 countries and territories, were obtained by predicting age-standardised IFR conditional on covariates and reversing the age standardisation. Findings We report IFR estimates for April 15, 2020, to January 1, 2021, the period before the introduction of vaccines and widespread evolution of variants. We found substantial heterogeneity in the IFR by age, location, and time. Agespecific IFR estimates form a J shape, with the lowest IFR occurring at age 7 years (0•0023%, 95% uncertainty interval [UI] 0•0015-0•0039) and increasing exponentially through ages 30 years (0•0573%, 0•0418-0•0870), 60 years (1•0035%, 0•7002-1•5727), and 90 years (20•3292%, 14•6888-28•9754). The countries with the highest IFR on July 15, 2020, were Portugal (2•085%, 0•946-4•395), Monaco (1•778%, 1•265-2•915), Japan (1•750%, 1•302-2•690), Spain (1•710%, 0•991-2•718), and Greece (1•637%, 1•155-2•678). All-age IFR varied by a factor..
Saint Vincent and the Grenadines Contributors Individual author contributions to the study are divided into the following categories: managing the estimation or publication process; writing the first draft of the manuscript; primary responsibility for applying analytical methods to produce estimates; primary responsibility for seeking, cataloguing, extracting, or cleaning data; designing or coding figures and tables; providing data or crucial feedback on data sources; development of methods or computational machinery; providing critical feedback on methods or results; drafting the manuscript or revising it critically for important intellectual content; designing or coding figures and tables; and managing the overall research enterprise. Members of the core research team for this topic area had full access to the underlying data used to generate estimates presented in this paper. All other authors had access to, and reviewed, estimates as part of the research evaluation process, which includes additional stages of formal review. Individual author contributions are listed in appendix 1 (p 21). Declaration of interests CA reports support for the present manuscript from the Benificus Foundation as funding support for the collection of data on state-level social-distancing policies in the USA. XD reports support for the present manuscript from the University of Washington through their employment at the Institute for Health Metrics and Evaluation. ADF reports stock or stock..
References
Ainsworth, Andersson, Auckland, Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison, Lancet Infect Dis
Arora, Joseph, Wyk, SeroTracker: a global SARS-CoV-2 seroprevalence dashboard, Lancet Infect Dis
Bartleson, Radenkovic, Covarrubias, Furman, Winer et al., SARS-CoV-2, COVID-19 and the aging immune system, Nat Aging
Bastos, Tavaziva, Abidi, Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis, BMJ
Bilinski, Emanuel, COVID-19 and excess all-cause mortality in the US and 18 comparison countries, JAMA
Bjørnstad, Shea, Krzywinski, Altman, Modeling infectious epidemics, Nat Methods
Bjørnstad, Shea, Krzywinski, Altman, The SEIRS model for infectious disease dynamics, Nat Methods
Boukhris, Hillani, Moroni, Cardiovascular implications of the COVID-19 pandemic: a global perspective, Can J Cardiol
Brazeau, Verity, Jenks, Report 34: COVID-19 infection fatality ratio: estimates from seroprevalence, Imperial College London
Burki, Estimating excess mortality due to the SARS-CoV-2 pandemic: a systematic analysis of COVID-19 related mortality between Jan 1, 2020, Lancet Respir Med
Deeks, Dinnes, Takwoingi, Antibody tests for identification of current and past infection with SARS-CoV-2, Cochrane Database Syst Rev
Dennis, Mcgovern, Vollmer, Mateen, Improving survival of critical care patients with coronavirus disease 2019 in England: a national cohort study, March to June 2020, Crit Care Med
Fullman, Yearwood, Abay, Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016, Lancet
Ghisolfi, Almås, Sandefur, Carnap, Heitner et al., Predicted COVID-19 fatality rates based on age, sex, comorbidities and health system capacity, BMJ Global Health
Glynn, Moss, Systematic analysis of infectious disease outcomes by age shows lowest severity in school-age children, Sci Data
Griffin, Zhu, Moore, Whitney, Grijalva, hospitalizations for pneumonia after a decade of pneumococcal vaccination, N Engl J Med
Ioannidis, Infection fatality rate of COVID-19 inferred from seroprevalence data, Bull World Health Organ
Levin, Hanage, Owusu-Boaitey, Cochran, Walsh et al., Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications, Eur J Epidemiol
Lloyd-Sherlock, Sempe, Mckee, Guntupalli, Problems of data availability and quality for COVID-19 and older people in low-and middle-income countries, Gerontologist
Lozano, Fullman, Mumford, Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet
Meyerowitz-Katz, Merone, A systematic review and metaanalysis of published research data on COVID-19 infection fatality rates, Int J Infect Dis
Murray, Ezzati, Flaxman, design, definitions, and metrics, Lancet
O'driscoll, Santos, Wang, Age-specific mortality and immunity patterns of SARS-CoV-2, Nature
Panovska-Griffiths, Kerr, Stuart, Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study, Lancet Child Adolesc Health
Reddy, Subramaniam, Afroz, Prone positioning of nonintubated patients with coronavirus disease 2019-a systematic review and meta-analysis, Crit Care Med
Reiner, Barber, Collins, Modeling COVID-19 scenarios for the United States, Nat Med
Riffe, Acosta, Schöley, Donzowa, COVerAGE-DB: a database of COVID-19 cases and deaths by age
Roth, Emmons-Bell, Alger, Trends in patient characteristics and COVID-19 in-hospital mortality in the United States during the COVID-19 pandemic, JAMA Netw Open
Sasson, Age and COVID-19 mortality: a comparison of Gompertz doubling time across countries and causes of death, Demogr Res
Schlüter, Sörensen, Bossert, Kersting, Staab et al., Anticipating the impact of COVID19 and comorbidities on the South African healthcare system by agent-based simulations, Sci Rep
Stevens, Alkema, Black, Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement, Lancet
The, Group, Dexamethasone in hospitalized patients with Covid-19-preliminary report, N Engl J Med
Thompson, Barbu, Beiu, The impact of COVID-19 pandemic on long-term care facilities worldwide: an overview on international issues, BioMed Res Int
Toner, Barnill, Krubiner, Interim framework for COVID-19 vaccine allocation and distribution in the United States
Vos, Lim, Abbafati, Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet
Wang, Abbas, Abbasifard, Global, regional, and national age-sex-specific fertility, mortality, and population estimates, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019, Lancet
Zheng, Barber, Sorensen, Murray, Aravkin, Trimmed constrained mixed effects models: formulations and algorithms, J Comput Graph Stat
Zimmermann, Curtis, Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections, Arch Dis Child
DOI record: { "DOI": "10.1016/s0140-6736(21)02867-1", "ISSN": [ "0140-6736" ], "URL": "http://dx.doi.org/10.1016/S0140-6736(21)02867-1", "alternative-id": [ "S0140673621028671" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis" }, { "label": "Journal Title", "name": "journaltitle", "value": "The Lancet" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/S0140-6736(21)02867-1" }, { "label": "CrossRef DOI link to the associated document", "name": "associatedlink", "value": "https://doi.org/10.1016/S0140-6736(22)00281-1" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2022 The Author(s). Published by Elsevier Ltd." } ], "container-title": "The Lancet", "container-title-short": "The Lancet", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.fr", "clinicalkey.jp", "clinicalkey.com.au", "clinicalkey.es", "clinicalkey.com", "em-consulte.com", "thelancet.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2022, 2, 24 ] ], "date-time": "2022-02-24T23:33:29Z", "timestamp": 1645745609000 }, "deposited": { "date-parts": [ [ 2022, 6, 30 ] ], "date-time": "2022-06-30T23:50:45Z", "timestamp": 1656633045000 }, "indexed": { "date-parts": [ [ 2024, 9, 20 ] ], "date-time": "2024-09-20T16:52:32Z", "timestamp": 1726851152923 }, "is-referenced-by-count": 188, "issue": "10334", "issued": { "date-parts": [ [ 2022, 4 ] ] }, "journal-issue": { "issue": "10334", "published-print": { "date-parts": [ [ 2022, 4 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 4, 1 ] ], "date-time": "2022-04-01T00:00:00Z", "timestamp": 1648771200000 } }, { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 1, 4 ] ], "date-time": "2022-01-04T00:00:00Z", "timestamp": 1641254400000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0140673621028671?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0140673621028671?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "1469-1488", "prefix": "10.1016", "published": { "date-parts": [ [ 2022, 4 ] ] }, "published-print": { "date-parts": [ [ 2022, 4 ] ] }, "publisher": "Elsevier BV", "reference": [ { "author": "Toner", "key": "10.1016/S0140-6736(21)02867-1_bib3", "series-title": "Interim framework for COVID-19 vaccine allocation and distribution in the United States", "year": "2020" }, { "DOI": "10.1136/bmjgh-2020-003094", "article-title": "Predicted COVID-19 fatality rates based on age, sex, comorbidities and health system capacity", "author": "Ghisolfi", "doi-asserted-by": "crossref", "journal-title": "BMJ Global Health", "key": "10.1016/S0140-6736(21)02867-1_bib4", "volume": "5", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30977-6", "article-title": "Global, regional, and national age-sex-specific fertility, mortality, and population estimates, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "1160", "journal-title": "Lancet", "key": "10.1016/S0140-6736(21)02867-1_bib5", "volume": "396", "year": "2020" }, { "DOI": "10.1038/s41592-020-0822-z", "article-title": "Modeling infectious epidemics", "author": "Bjørnstad", "doi-asserted-by": "crossref", "first-page": "455", "journal-title": "Nat Methods", "key": "10.1016/S0140-6736(21)02867-1_bib6", "volume": "17", "year": "2020" }, { "DOI": "10.1038/s41592-020-0856-2", "article-title": "The SEIRS model for infectious disease dynamics", "author": "Bjørnstad", "doi-asserted-by": "crossref", "first-page": "557", "journal-title": "Nat Methods", "key": "10.1016/S0140-6736(21)02867-1_bib7", "volume": "17", "year": "2020" }, { "DOI": "10.1038/s41591-020-1132-9", "article-title": "Modeling COVID-19 scenarios for the United States", "author": "Reiner", "doi-asserted-by": "crossref", "first-page": "94", "journal-title": "Nat Med", "key": "10.1016/S0140-6736(21)02867-1_bib8", "volume": "27", "year": "2021" }, { "author": "Brazeau", "key": "10.1016/S0140-6736(21)02867-1_bib9", "series-title": "Report 34: COVID-19 infection fatality ratio: estimates from seroprevalence", "year": "2020" }, { "DOI": "10.1016/j.ijid.2020.09.1464", "article-title": "A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates", "author": "Meyerowitz-Katz", "doi-asserted-by": "crossref", "first-page": "138", "journal-title": "Int J Infect Dis", "key": "10.1016/S0140-6736(21)02867-1_bib10", "volume": "101", "year": "2020" }, { "DOI": "10.2471/BLT.20.265892", "article-title": "Infection fatality rate of COVID-19 inferred from seroprevalence data", "author": "Ioannidis", "doi-asserted-by": "crossref", "first-page": "19", "journal-title": "Bull World Health Organ", "key": "10.1016/S0140-6736(21)02867-1_bib11", "volume": "99", "year": "2021" }, { "DOI": "10.1007/s10654-020-00698-1", "article-title": "Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications", "author": "Levin", "doi-asserted-by": "crossref", "first-page": "1123", "journal-title": "Eur J Epidemiol", "key": "10.1016/S0140-6736(21)02867-1_bib12", "volume": "35", "year": "2020" }, { "DOI": "10.1038/s41586-020-2918-0", "article-title": "Age-specific mortality and immunity patterns of SARS-CoV-2", "author": "O'Driscoll", "doi-asserted-by": "crossref", "first-page": "140", "journal-title": "Nature", "key": "10.1016/S0140-6736(21)02867-1_bib13", "volume": "590", "year": "2021" }, { "DOI": "10.1016/S2213-2600(21)00443-4", "article-title": "The race between vaccination and evolution of COVID-19 variants", "author": "Burki", "doi-asserted-by": "crossref", "first-page": "e109", "journal-title": "Lancet Respir Med", "key": "10.1016/S0140-6736(21)02867-1_bib14", "volume": "9", "year": "2021" }, { "key": "10.1016/S0140-6736(21)02867-1_bib15", "unstructured": "COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the SARS-CoV-2 pandemic: a systematic analysis of COVID-19 related mortality between Jan 1, 2020, and December 31, 2021. Lancet (in press)." }, { "DOI": "10.1016/S0140-6736(12)61899-6", "article-title": "GBD 2010: design, definitions, and metrics", "author": "Murray", "doi-asserted-by": "crossref", "first-page": "2063", "journal-title": "Lancet", "key": "10.1016/S0140-6736(21)02867-1_bib17", "volume": "380", "year": "2012" }, { "DOI": "10.1016/S0140-6736(16)30388-9", "article-title": "Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement", "author": "Stevens", "doi-asserted-by": "crossref", "first-page": "e19", "journal-title": "Lancet", "key": "10.1016/S0140-6736(21)02867-1_bib18", "volume": "388", "year": "2016" }, { "author": "Riffe", "key": "10.1016/S0140-6736(21)02867-1_bib19" }, { "article-title": "Trimmed constrained mixed effects models: formulations and algorithms", "author": "Zheng", "first-page": "1", "journal-title": "J Comput Graph Stat", "key": "10.1016/S0140-6736(21)02867-1_bib20", "volume": "1", "year": "2021" }, { "DOI": "10.1016/S1473-3099(20)30631-9", "article-title": "SeroTracker: a global SARS-CoV-2 seroprevalence dashboard", "author": "Arora", "doi-asserted-by": "crossref", "first-page": "e75", "journal-title": "Lancet Infect Dis", "key": "10.1016/S0140-6736(21)02867-1_bib21", "volume": "21", "year": "2021" }, { "DOI": "10.1016/S0140-6736(18)30994-2", "article-title": "Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016", "author": "Fullman", "doi-asserted-by": "crossref", "first-page": "2236", "journal-title": "Lancet", "key": "10.1016/S0140-6736(21)02867-1_bib22", "volume": "391", "year": "2018" }, { "DOI": "10.1016/S0140-6736(20)30750-9", "article-title": "Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019", "author": "Lozano", "doi-asserted-by": "crossref", "first-page": "1250", "journal-title": "Lancet", "key": "10.1016/S0140-6736(21)02867-1_bib23", "volume": "396", "year": "2020" }, { "DOI": "10.1001/jamanetworkopen.2021.8828", "article-title": "Trends in patient characteristics and COVID-19 in-hospital mortality in the United States during the COVID-19 pandemic", "author": "Roth", "doi-asserted-by": "crossref", "journal-title": "JAMA Netw Open", "key": "10.1016/S0140-6736(21)02867-1_bib25", "volume": "4", "year": "2021" }, { "DOI": "10.1038/s43587-021-00114-7", "article-title": "SARS-CoV-2, COVID-19 and the aging immune system", "author": "Bartleson", "doi-asserted-by": "crossref", "first-page": "769", "journal-title": "Nat Aging", "key": "10.1016/S0140-6736(21)02867-1_bib26", "volume": "1", "year": "2021" }, { "DOI": "10.1136/archdischild-2020-320338", "article-title": "Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections", "author": "Zimmermann", "doi-asserted-by": "crossref", "first-page": "429", "journal-title": "Arch Dis Child", "key": "10.1016/S0140-6736(21)02867-1_bib27", "volume": "106", "year": "2021" }, { "DOI": "10.1038/s41597-020-00668-y", "article-title": "Systematic analysis of infectious disease outcomes by age shows lowest severity in school-age children", "author": "Glynn", "doi-asserted-by": "crossref", "first-page": "329", "journal-title": "Sci Data", "key": "10.1016/S0140-6736(21)02867-1_bib28", "volume": "7", "year": "2020" }, { "DOI": "10.1016/S2352-4642(20)30250-9", "article-title": "Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study", "author": "Panovska-Griffiths", "doi-asserted-by": "crossref", "first-page": "817", "journal-title": "Lancet Child Adolesc Health", "key": "10.1016/S0140-6736(21)02867-1_bib30", "volume": "4", "year": "2020" }, { "DOI": "10.1056/NEJMoa1209165", "article-title": "U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination", "author": "Griffin", "doi-asserted-by": "crossref", "first-page": "155", "journal-title": "N Engl J Med", "key": "10.1016/S0140-6736(21)02867-1_bib31", "volume": "369", "year": "2013" }, { "DOI": "10.1016/S0140-6736(20)30925-9", "article-title": "Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019", "author": "Vos", "doi-asserted-by": "crossref", "first-page": "1204", "journal-title": "Lancet", "key": "10.1016/S0140-6736(21)02867-1_bib32", "volume": "396", "year": "2020" }, { "DOI": "10.4054/DemRes.2021.44.16", "article-title": "Age and COVID-19 mortality: a comparison of Gompertz doubling time across countries and causes of death", "author": "Sasson", "doi-asserted-by": "crossref", "first-page": "379", "journal-title": "Demogr Res", "key": "10.1016/S0140-6736(21)02867-1_bib34", "volume": "44", "year": "2021" }, { "DOI": "10.1155/2020/8870249", "article-title": "The impact of COVID-19 pandemic on long-term care facilities worldwide: an overview on international issues", "author": "Thompson", "doi-asserted-by": "crossref", "journal-title": "BioMed Res Int", "key": "10.1016/S0140-6736(21)02867-1_bib35", "volume": "2020", "year": "2020" }, { "DOI": "10.1093/geront/gnaa153", "article-title": "Problems of data availability and quality for COVID-19 and older people in low- and middle-income countries", "author": "Lloyd-Sherlock", "doi-asserted-by": "crossref", "first-page": "141", "journal-title": "Gerontologist", "key": "10.1016/S0140-6736(21)02867-1_bib36", "volume": "61", "year": "2021" }, { "DOI": "10.1056/NEJMoa2021436", "article-title": "Dexamethasone in hospitalized patients with Covid-19—preliminary report", "doi-asserted-by": "crossref", "first-page": "693", "journal-title": "N Engl J Med", "key": "10.1016/S0140-6736(21)02867-1_bib37", "volume": "384", "year": "2021" }, { "DOI": "10.1097/CCM.0000000000005086", "article-title": "Prone positioning of nonintubated patients with coronavirus disease 2019—a systematic review and meta-analysis", "author": "Reddy", "doi-asserted-by": "crossref", "first-page": "e1001", "journal-title": "Crit Care Med", "key": "10.1016/S0140-6736(21)02867-1_bib38", "volume": "49", "year": "2021" }, { "DOI": "10.1097/CCM.0000000000004747", "article-title": "Improving survival of critical care patients with coronavirus disease 2019 in England: a national cohort study, March to June 2020", "author": "Dennis", "doi-asserted-by": "crossref", "first-page": "209", "journal-title": "Crit Care Med", "key": "10.1016/S0140-6736(21)02867-1_bib39", "volume": "49", "year": "2021" }, { "DOI": "10.1016/S1473-3099(20)30634-4", "article-title": "Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison", "author": "Ainsworth", "doi-asserted-by": "crossref", "first-page": "1390", "journal-title": "Lancet Infect Dis", "key": "10.1016/S0140-6736(21)02867-1_bib40", "volume": "20", "year": "2020" }, { "article-title": "Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis", "author": "Bastos", "journal-title": "BMJ", "key": "10.1016/S0140-6736(21)02867-1_bib41", "volume": "370", "year": "2020" }, { "article-title": "Antibody tests for identification of current and past infection with SARS-CoV-2", "author": "Deeks", "journal-title": "Cochrane Database Syst Rev", "key": "10.1016/S0140-6736(21)02867-1_bib42", "volume": "6", "year": "2020" }, { "DOI": "10.1001/jama.2020.20717", "article-title": "COVID-19 and excess all-cause mortality in the US and 18 comparison countries", "author": "Bilinski", "doi-asserted-by": "crossref", "first-page": "2100", "journal-title": "JAMA", "key": "10.1016/S0140-6736(21)02867-1_bib44", "volume": "324", "year": "2020" }, { "DOI": "10.1016/j.cjca.2020.05.018", "article-title": "Cardiovascular implications of the COVID-19 pandemic: a global perspective", "author": "Boukhris", "doi-asserted-by": "crossref", "first-page": "1068", "journal-title": "Can J Cardiol", "key": "10.1016/S0140-6736(21)02867-1_bib45", "volume": "36", "year": "2020" }, { "DOI": "10.1038/s41598-021-86580-w", "article-title": "Anticipating the impact of COVID19 and comorbidities on the South African healthcare system by agent-based simulations", "author": "Schlüter", "doi-asserted-by": "crossref", "journal-title": "Sci Rep", "key": "10.1016/S0140-6736(21)02867-1_bib33", "volume": "11", "year": "2021" } ], "reference-count": 39, "references-count": 39, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0140673621028671" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Variation in the COVID-19 infection–fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "399" }
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit